Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter II Neoplasms,CD2_BENIGN_ASCENDING_COLON,PRSS2,Trypsin-2,Inverse variance weighted,3,1.34 [0.97-1.85],0.0724318980098324,cis
Chapter II Neoplasms,CD2_BENIGN_ASCENDING_COLON,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.93 [0.65-1.33],0.695421705827678,cis
Chapter II Neoplasms,CD2_BENIGN_ASCENDING_COLON,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.98 [0.82-1.17],0.815449846962989,cis
Chapter II Neoplasms,CD2_BENIGN_ASCENDING_COLON,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,0.99 [0.73-1.34],0.94301278462037,cis
Chapter II Neoplasms,CD2_BENIGN_ASCENDING_COLON,GAST,Gastrin,Inverse variance weighted,9,1.34 [1.02-1.77],0.0370667503465167,trans
Chapter II Neoplasms,CD2_BENIGN_ASCENDING_COLON,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,0.8 [0.62-1.02],0.0713614737177153,trans
Chapter II Neoplasms,CD2_BENIGN_ASCENDING_COLON,PRSS2,Trypsin-2,Inverse variance weighted,17,0.83 [0.66-1.03],0.0930894358090394,trans
Chapter II Neoplasms,CD2_BENIGN_ASCENDING_COLON,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.95 [0.77-1.17],0.632448193929465,trans
Chapter II Neoplasms,CD2_BENIGN_ASCENDING_COLON,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.01 [0.87-1.17],0.939383163729208,trans
